Literature DB >> 21156891

Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: an update.

Aleksey Kazmin1, Renee C Wong, Mathew Sermer, Gideon Koren.   

Abstract

QUESTION: What is the current evidence regarding the association between hemorrhagic disease of the newborn and maternal use of hepatic enzyme-inducing antiepileptic drugs (eg, carbamazepine, phenobarbitone, topiramate)? ANSWER: Women with epilepsy who take enzyme-inducing antiepileptic drugs should be advised that there is no adequate evidence to support or refute taking vitamin K in late pregnancy to prevent bleeding complications in a newborn.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21156891      PMCID: PMC3001920     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  11 in total

Review 1.  Vitamin K prophylaxis--a useful public health measure?

Authors:  R von Kries
Journal:  Paediatr Perinat Epidemiol       Date:  1992-01       Impact factor: 3.980

Review 2.  Vitamin K.

Authors:  M J Shearer
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

3.  Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors: 
Journal:  Epilepsia       Date:  1998-11       Impact factor: 5.864

4.  Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.

Authors:  K R Mountain; J Hirsh; A S Gallus
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

5.  Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother.

Authors:  M F Deblay; P Vert; M Andre; F Marchal
Journal:  Lancet       Date:  1982-05-29       Impact factor: 79.321

6.  Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate.

Authors:  Erja Kaaja; Risto Kaaja; Riitta Matila; Vilho Hiilesmaa
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

7.  Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants?

Authors:  Sophie Choulika; Eric Grabowski; Lewis B Holmes
Journal:  Am J Obstet Gynecol       Date:  2004-04       Impact factor: 8.661

Review 8.  Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Authors:  C L Harden; P B Pennell; B S Koppel; C A Hovinga; B Gidal; K J Meador; J Hopp; T Y Ting; W A Hauser; D Thurman; P W Kaplan; J N Robinson; J A French; S Wiebe; A N Wilner; B Vazquez; L Holmes; A Krumholz; R Finnell; P O Shafer; C Le Guen
Journal:  Neurology       Date:  2009-04-27       Impact factor: 9.910

9.  Haemorrhagic disease of the newborn in the British Isles: two year prospective study.

Authors:  A W McNinch; J H Tripp
Journal:  BMJ       Date:  1991-11-02

Review 10.  Vitamin K in neonates: how to administer, when and to whom.

Authors:  E Autret-Leca; A P Jonville-Béra
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.930

View more
  2 in total

Review 1.  Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.

Authors:  Richard A Epstein; Katherine M Moore; William V Bobo
Journal:  Drug Healthc Patient Saf       Date:  2014-12-24

2.  Vitamin K supplementation during pregnancy for improving outcomes: a systematic review and meta-analysis.

Authors:  Sadequa Shahrook; Erika Ota; Nobutsugu Hanada; Kimi Sawada; Rintaro Mori
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.